GENE ONLINE|News &
Opinion
Blog

2025-12-01|

Oxidized Phosphatidylcholines Linked to Chronic Neurodegeneration in Progressive Multiple Sclerosis

by GOAI
Share To

Researchers have identified oxidized phosphatidylcholines (OxPCs) as significant contributors to chronic neurodegeneration in progressive multiple sclerosis (P-MS). The study highlights OxPCs, which are neurotoxic byproducts generated through oxidative stress, as a central factor driving the disease’s pathology. This finding provides insight into the molecular mechanisms underlying P-MS and suggests potential avenues for therapeutic development.

The research outlines how OxPCs interact with interleukin-1 beta (IL-1β), a pro-inflammatory cytokine, to exacerbate neurodegenerative processes in P-MS. Oxidative stress leads to the formation of OxPCs, which then trigger inflammatory responses mediated by IL-1β. This interaction is believed to play a critical role in the progression of chronic neuroinflammation and neuronal damage observed in patients with P-MS. The study emphasizes the importance of targeting these pathways to mitigate disease progression and improve patient outcomes.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Takeda R&D President Andy Plump and GV Managing Partner Krishna Yeshwant Announce Retirements
2026-09-12
Shine Spect USA Updates Clinical and Safety Guidelines for Xenon Xe-133 Gas
2026-09-11
Amorepacific Updates Hera Black Cushion Ingredient Disclosures for Ten Foundation Shades
2026-09-11
AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring
2026-09-11
Record Investor Attendance at NLS Days 2026 Drives Nordic Life Science Dealmaking
2026-09-11
Disc Medicine and Silence Therapeutics Develop Polycythemia Vera Treatments to Compete With Takeda and Protagonist
2026-09-11
Leucine Supplementation Linked to Reduced Lymphoid Malignancy Growth and Improved Survival in Study
2026-09-11
Scroll to Top